JP2023512557A5 - - Google Patents
Info
- Publication number
- JP2023512557A5 JP2023512557A5 JP2022547846A JP2022547846A JP2023512557A5 JP 2023512557 A5 JP2023512557 A5 JP 2023512557A5 JP 2022547846 A JP2022547846 A JP 2022547846A JP 2022547846 A JP2022547846 A JP 2022547846A JP 2023512557 A5 JP2023512557 A5 JP 2023512557A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- alkyl
- formula
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062970832P | 2020-02-06 | 2020-02-06 | |
| US62/970,832 | 2020-02-06 | ||
| PCT/US2021/016698 WO2021158840A1 (en) | 2020-02-06 | 2021-02-05 | Macrocyclic pad4 inhibitors useful as immunosuppressant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512557A JP2023512557A (ja) | 2023-03-27 |
| JP2023512557A5 true JP2023512557A5 (https=) | 2024-02-06 |
| JP7711073B2 JP7711073B2 (ja) | 2025-07-22 |
Family
ID=74798090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547846A Active JP7711073B2 (ja) | 2020-02-06 | 2021-02-05 | 免疫抑制剤として有用な大環状ｐａｄ４阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12492202B2 (https=) |
| EP (1) | EP4100405A1 (https=) |
| JP (1) | JP7711073B2 (https=) |
| KR (1) | KR20220137694A (https=) |
| CN (1) | CN115298175B (https=) |
| WO (1) | WO2021158840A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021158840A1 (en) | 2020-02-06 | 2021-08-12 | Bristol-Myers Squibb Company | Macrocyclic pad4 inhibitors useful as immunosuppressant |
| TW202140477A (zh) | 2020-02-12 | 2021-11-01 | 美商必治妥美雅史谷比公司 | 雜環ｐａｄ４抑制劑 |
| WO2021222353A1 (en) | 2020-04-30 | 2021-11-04 | Gilead Sciences, Inc. | Macrocyclic inhibitors of peptidylarginine deiminases |
| TW202233174A (zh) | 2020-12-22 | 2022-09-01 | 美商基利科學股份有限公司 | 肽基精胺酸去亞胺酶之抑制劑 |
| WO2022140390A1 (en) | 2020-12-22 | 2022-06-30 | Gilead Sciences, Inc. | Inhibitors of peptidylarginine deiminases |
| KR20260041867A (ko) | 2023-07-21 | 2026-03-27 | 브리스톨-마이어스 스큅 컴퍼니 | Pad4 조정제의 시트룰린화 및 활성을 평가하는 방법 |
| WO2026020127A2 (en) | 2024-07-19 | 2026-01-22 | Bristol-Myers Squibb Company | Methods of assessing citrullination and activity of pad2 modulators |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101916443B1 (ko) * | 2012-07-26 | 2018-11-08 | 글락소 그룹 리미티드 | Pad4 억제제로서의 2-(아자인돌-2-일) 벤즈이미다졸 |
| KR20180005250A (ko) * | 2015-05-21 | 2018-01-15 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Pad4 억제제로서의 벤조이미다졸 유도체 |
| AR107032A1 (es) * | 2015-12-09 | 2018-03-14 | Padlock Therapeutics Inc | Inhibidores bicíclicos de pad4 |
| AR107030A1 (es) | 2015-12-09 | 2018-03-14 | Padlock Therapeutics Inc | Inhibidores aza-bencimidazol de pad4 |
| CA3015482A1 (en) | 2016-02-23 | 2017-08-31 | Padlock Therapeutics, Inc. | Heteroaryl inhibitors of pad4 |
| WO2018022897A1 (en) | 2016-07-27 | 2018-02-01 | Padlock Therapeutics, Inc. | Covalent inhibitors of pad4 |
| US11026937B2 (en) | 2016-09-12 | 2021-06-08 | Padlock Therapeutics, Inc. | Heteroaryl inhibitors of PAD4 |
| MX2021001471A (es) | 2018-08-08 | 2021-04-28 | Bristol Myers Squibb Co | Benzimidazoles sustituidos como inhibidores de peptidil arginina deiminasa 4 (pad4). |
| JP7447080B2 (ja) | 2018-08-08 | 2024-03-11 | ブリストル－マイヤーズ スクイブ カンパニー | Ｐａｄ４阻害剤としての置換チエノピロール |
| MX2021001565A (es) | 2018-08-08 | 2021-04-19 | Bristol Myers Squibb Co | Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad). |
| US20220348562A1 (en) | 2018-08-08 | 2022-11-03 | Bristol-Myers Squibb Company | Benzimidazole inhibitors of pad enzymes |
| WO2021158840A1 (en) | 2020-02-06 | 2021-08-12 | Bristol-Myers Squibb Company | Macrocyclic pad4 inhibitors useful as immunosuppressant |
| TW202140477A (zh) | 2020-02-12 | 2021-11-01 | 美商必治妥美雅史谷比公司 | 雜環ｐａｄ４抑制劑 |
-
2021
- 2021-02-05 WO PCT/US2021/016698 patent/WO2021158840A1/en not_active Ceased
- 2021-02-05 CN CN202180022507.5A patent/CN115298175B/zh active Active
- 2021-02-05 JP JP2022547846A patent/JP7711073B2/ja active Active
- 2021-02-05 EP EP21708867.3A patent/EP4100405A1/en active Pending
- 2021-02-05 KR KR1020227030292A patent/KR20220137694A/ko active Pending
- 2021-02-05 US US17/760,309 patent/US12492202B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023512557A5 (https=) | ||
| JP2021534108A5 (https=) | ||
| JP2021534097A5 (https=) | ||
| JP2021534106A5 (https=) | ||
| JP2021534104A5 (https=) | ||
| JP2009543802A5 (https=) | ||
| JP2009535307A5 (https=) | ||
| JP2008510828A5 (https=) | ||
| JP2021532109A5 (https=) | ||
| JP2009523724A5 (https=) | ||
| RU2015143717A (ru) | 2-Аминопиримидин-6-оны и аналоги, проявляющие противораковые и антипролиферативные действия | |
| JP2023539949A5 (https=) | ||
| JP2016508505A5 (https=) | ||
| JP2012507522A5 (https=) | ||
| JP2011527686A5 (https=) | ||
| JP2001510843A5 (https=) | ||
| JP2004524340A5 (https=) | ||
| JP2021519785A5 (https=) | ||
| JP2020122016A5 (https=) | ||
| JP2006504621A5 (https=) | ||
| JP2023518035A5 (https=) | ||
| JP2005529155A5 (https=) | ||
| WO2015057692A1 (en) | Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy | |
| JP2006509842A5 (https=) | ||
| JP2024526849A5 (https=) |